KNSA Since 2018 Annualized Return and Average Annual Return

KNSA Average Annual Return Chart Since 2018
Growth of $10,000.00
Without Dividends Reinvested Into KNSA

Also see:
• KNSA stock yearly return 2019
• KNSA stock yearly return 2020
• KNSA stock yearly return 2021
• KNSA stock yearly return 2022
• KNSA stock yearly return 2023
• KNSA stock yearly return 2024
• KNSA stock yearly return 2025
• KNSA YTD return
Average Annual Return Benchmarks
Compare KNSA average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
KNSA Share Performance
KNSA Average Annual Return Table Since 2018
Start date: 05/29/2018
End date: 09/11/2026
Start price/share: $17.21
End price/share: $76.27
Dividends collected/share: $0.00
Total return: 343.17%
KNSA Average Annual Return: 19.66%
Starting investment: $10,000.00
Ending investment: $44,303.98
Years: 8.29


KNSA average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Kiniksa Pharmaceuticals International plc
Kiniksa Pharmaceuticals, Ltd. is a biopharmaceutical company. Co. is focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its portfolio of immune-modulating assets, ARCALYST (rilonacept), KPL-404 and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. Co.'s ARCALYST is interleukin-1alpha (IL-1?), and interleukin-1beta (IL-1?), cytokine trap for the treatment of recurrent pericarditis and reduction in risk of recurrence in adults and children. The KNSA average annual return since 2018 is shown above.

The Average Annual Return on the KNSA average annual return since 2018 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether KNSA average annual return since 2018 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the KNSA average annual return calculation with any dividends reinvested as applicable (on ex-dates).
KNSA Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree KNSA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
 

KNSA Average Annual Return Since 2018 | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.